Ampio Pharmaceuticals, Inc. (AMPE) financial statements (2022 and earlier)

Company profile

Business Address 373 INVERNESS PARKWAY
ENGLEWOOD, CO 80112
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments33,89217,3466,5327,5858,2205,01726,958
Cash and cash equivalents33,89217,3466,5327,5858,2094,89526,958
Short-term investments    11123 
Prepaid expense6869531   2,005
Derivative instruments and hedges, assets    12123 
Other current assets      2,270
Other undisclosed current assets1,6721,0781,187413210262(2,005)
Total current assets:35,63218,4938,2507,9998,4435,40229,228
Noncurrent Assets
Operating lease, right-of-use asset6298241,003
Property, plant and equipment2,5643,5614,7485,9986,8387,9809,331
Intangible assets, net (including goodwill)      3,131
Goodwill      221
Intangible assets, net (excluding goodwill)      2,910
Regulated entity, other noncurrent assets      253
Deposits noncurrent assets   34343437
Other undisclosed noncurrent assets     1808,438
Total noncurrent assets:3,1934,3855,7516,0316,8728,19421,190
TOTAL ASSETS:38,82522,87814,00114,03015,31513,59650,419
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4,8111,5504,0251,3252,7867092,881
Accounts payable427186151   2,881
Accrued liabilities731420368    
Employee-related liabilities389 72    
Other undisclosed accounts payable and accrued liabilities3,2649443,4341,3252,786709 
Debt 284259    
Deferred rent credit   60
Due to related parties      1,111
Deferred revenue and credits6060145
Other undisclosed current liabilities311   1,0331,3661,378
Total current liabilities:5,1221,8344,2841,3843,8782,1355,515
Noncurrent Liabilities
Long-term debt and lease obligation6149251,210   4,922
Long-term debt, excluding current maturities      4,922
Operating lease, liability6149251,210
Liabilities, other than long-term debt5,8052,6072,0647,41045,6134,8271,893
Deferred revenue and credits5375881,024
Deferred rent credit   477
Business combination, contingent consideration, liability      688
Derivative instruments and hedges, liabilities5,8052,6072,0646,93345,0764,239181
Other undisclosed noncurrent liabilities      162
Total noncurrent liabilities:6,4193,5323,2747,41045,6134,8276,976
Total liabilities:11,5415,3667,5588,79449,4916,96112,492
Stockholders' equity
Stockholders' equity attributable to parent, including:27,28417,5126,4435,23634,2006,63436,999
Common stock23191611865
Additional paid in capital244,863218,020191,060176,228170,804159,732170,999
Accumulated deficit(217,602)(200,527)(184,633)(171,003)(204,989)(153,078)(133,915)
Other undisclosed stockholders' equity attributable to parent    68,377(25)(91)
Stockholders' equity attributable to noncontrolling interest      928
Other undisclosed stockholders' equity    (68,377)  
Total stockholders' equity:27,28417,5126,4435,236(34,177)6,63437,927
TOTAL LIABILITIES AND EQUITY:38,82522,87814,00114,03015,31513,59650,419

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues      1,162
Revenue, net  1,077
Cost of revenue
(Cost of Goods and Services Sold)
      (369)
Gross profit:      793
Operating expenses(20,571)(15,834)(18,576)(11,184)(15,565)(17,082)(34,465)
Other operating income, net   45,170   
Other undisclosed operating income      369
Operating income (loss):(20,571)(15,834)(18,576)33,986(15,565)(17,082)(33,302)
Nonoperating income (expense)3,496(60)4,946 (36,327)(2,081)(412)
Investment income, nonoperating3,492(543)4,869 (36,219)(915)(78)
Interest and debt expense      (148)
Income (loss) before gain (loss) on sale of properties:(17,075)(15,894)(13,630)33,986(51,892)(19,164)(33,862)
Other undisclosed net income      148
Net income (loss):(17,075)(15,894)(13,630)33,986(51,892)(19,164)(33,714)
Net income attributable to noncontrolling interest      1,704
Net income (loss) attributable to parent:(17,075)(15,894)(13,630)33,986(51,892)(19,164)(32,010)
Preferred stock dividends and other adjustments(3,492) (4,869)    
Net income (loss) available to common stockholders, diluted:(20,567)(15,894)(18,499)33,986(51,892)(19,164)(32,010)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(17,075)(15,894)(13,630)33,986(51,892)(19,164)(33,714)
Comprehensive income (loss):(17,075)(15,894)(13,630)33,986(51,892)(19,164)(33,714)
Comprehensive income, net of tax, attributable to noncontrolling interest      1,704
Comprehensive income (loss), net of tax, attributable to parent:(17,075)(15,894)(13,630)33,986(51,892)(19,164)(32,010)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: